| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.32 | 0.03 |